Clinical evidence for hepatitis B transmission resulting from corneal transplantation

Cornea

Volumn 16, Issue 2, 1997, Pages 132-137

  Hoft, Richard H ^a   Pflugfelder, Stephen C ^b   Forster, Richard K ^b   Ullman, Saul ^c   Polack, Frank M ^d   Schiff, Eugene R ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c Medical Center Clinic Pensacola   (United States)

^d UNIVERSITY OF FLORIDA   (United States)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Corneal transplantation; Donor corneal tissue; Eye banking; Hepatitis B transmission; Hepatitis B virus (HBV) infection; Keratoplasty; Tissue transplantation

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CORNEA TRANSPLANTATION; EYEBANK; HEPATITIS B; HUMAN; KERATOPLASTY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0030941467     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003226-199703000-00003     Document Type: Article

References (17)

1. Mannis MJ, Reinhart WJ. Medical standards for eye bank development. In: Brightbill FS, ed. Corneal surgery: theory, technique, and tissue, 2nd ed. St. Louis: Mosby, 1993:531-48.
2. Food and Drug Administration. Interim rule for human tissue intended for transplantation, 12/14/93. Fed Regist 1993;58:65514.
3. Gandhi SS, Lamberts DW, Perry HD. Donor to host transmission of disease via corneal transplantation. Surv Ophthalmol 1981;15: 306-11.
4. O'Day D. Disease potentially transmitted through corneal transplantation. Ophthalmology 1989;96:1133-8.
5. Hollinger FB. Hepatitis B virus. In: Fields BN, Knipe DM, eds. Virology. New York: Raven Press, 1990:2171-236.
6. Public Health Service. Interagency Guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR 1991;40:1-17.
7. Koff RS. Viral hepatitis. In: Schiff L, Schiff ER, eds. Disease of the liver, 7th ed. Philadelphia: Lippincott, 1993:492-577.
8. Conway MD, Insler MS. The identification and incidence of human immunodeficiency virus antibodies and hepatitis B virus antigens in corneal donors. Ophthalmology 1988;95:1463-7.
9. Bialasiewicz AA, Jahn GJ. Screening for potentially pathogenic agents in cornea donors. Am J Ophthalmol 1987;103:104-5.
10. Darrell RW, Jacob GB. Hepatitis B surface antigen in human tears. Arch Ophthalmol 1978;96:674-6.
11. Raber IM, Friedman HM. Hepatitis B surface antigen in corneal donors. Am J Ophthalmol 1987;104:255-8.
12. DeVoe AG. Complications of keratoplasty. Am J Ophthalmol 1975;79:907-12.
13. Pepose JS, MacRae S, Quinn TC, Holland GN. The impact of the AIDS epidemic on corneal transplantation. Am J Ophthalmol 1985; 100:610-3.
14. Doro S, Navia BA, Kahn A, Pumarola-Sunke T, et al. Confirmation of HTLV-III virus in cornea. Am J Ophthalmol 1986;102: 390-1.
15. Salahuddin SZ, Palestine AG, Heck E, et al. Isolation of the human T-cell leukemia/ymphotrophic virus type III from cornea. Am J Ophthalmol 1986;101:149-52.
16. Pepose JS, MacRae S, Quinn TC, et al. Serologic markers after the transplantation of corneas from donors infected with human immunodeficiency virus. Am J Ophthalmol 1987;103:798-801.
17. Pepose JS, Buerger DG, Paul DA, Quinn TC, Darragh TM, Donegan E. New developments in serologic screening of corneal donors for HIV-1 and hepatitis B infection. Ophthalmology 1992; 99:879-88.